New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration

New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration

SHANGHAI, Aug. 12, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration...

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with...

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 24, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in...

BIOHK2026 (Hong Kong International Biotechnology Conference and Exhibition), 9-12 September, Hong Kong - Connecting Global Leaders in Biotechnology

BIOHK2026 (Hong Kong International Biotechnology Conference and Exhibition), 9-12 September, Hong Kong - Connecting Global Leaders in Biotechnology

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September. HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong Kong International Biotechnology Conference and...

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC

SHANGHAI, July 2, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN) to...

The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation

The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation

BEIJING, June 26, 2026 /PRNewswire/ -- The Fourth China International Supply Chain Expo (CISCE) has opened its Healthy Life Chain section, drawing more than 100 leading companies across three core zones—Medical Technology, Quality Living, and...

The 7th Qingdao Multinationals Summit Kicks Off: Joining Hands for the 15th Five-Year Plan to Build a New Ecosystem of Openness and Cooperation

The 7th Qingdao Multinationals Summit Kicks Off: Joining Hands for the 15th Five-Year Plan to Build a New Ecosystem of Openness and Cooperation

QINGDAO, China, June 16, 2026 /PRNewswire/ -- The 7th Qingdao Multinationals Summit (QMS), co-hosted by the Shandong Provincial People's Government and the Ministry of Commerce, opened in Qingdao from June 15 to 17, 2026. The summit officially...

Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World's Most Pressing Challenges

Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World's Most Pressing Challenges

SILICON VALLEY, Calif., June 16, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is pleased to present the 2026 Visionary Growth Leadership Best Practices Recognition, celebrating leading enterprises that are redefining the role of business...

NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiency

NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiency

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 8, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...

NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History

NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...

  • 1
  • 2
  • 3
  • 4
  • menu
    menu